Isabel Kallman grapples with perimenopause symptoms and the decision to consider hormone therapy. Experts argue that the risks associated with treatment may have been overstated, calling for a reevaluation of FDA warnings.
Menopause can bring disruptive symptoms, but hormone therapy offers relief. Experts discuss its benefits and risks, urging women to make informed decisions about their treatment options.
Doctors are pushing the FDA to remove black box warnings on low-dose estrogen treatments, arguing it discourages women from beneficial hormone therapies for menopause. Experts claim the risks are overstated and can hinder treatment.
Recent clinical trials show that GLP-1 weight loss medications like Zepbound are more effective for women than men, prompting researchers to explore the biological and societal reasons behind this phenomenon.
